Team:Westminster/Team
From 2012.igem.org
Line 1: | Line 1: | ||
- | |||
- | |||
<html> | <html> | ||
+ | |||
<head> | <head> | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | < | + | <meta http-equiv="content-type" content="text/php; charset=utf-8" /> |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
+ | <style type="text/css"> | ||
+ | @import url 'http://yui.yahooapis.com/2.9.0/build/reset/reset-min.css'; | ||
+ | ul { | ||
+ | list-style: none; | ||
+ | } | ||
+ | body { | ||
+ | font-family: "HelveticaNeue-Light", "Helvetica Neue Light", "Helvetica Neue", Helvetica, Arial, "Lucida Grande", sans-serif; | ||
+ | font-weight: 300; | ||
+ | background: url("http://www.westminsterigem.com/files/theme/body-bg.png") repeat #ffffff; | ||
+ | color: #666666; | ||
+ | } | ||
+ | h1 { | ||
+ | color: #ff0000; | ||
+ | font-size: 18pt; | ||
+ | margin-bottom: 0.5em; | ||
+ | } | ||
+ | p { | ||
+ | |||
+ | } | ||
+ | a { | ||
+ | |||
+ | } | ||
+ | #p-logo { | ||
+ | background: #444444; | ||
+ | } | ||
+ | div#top-section, | ||
+ | div#content { | ||
+ | box-shadow: 0px 0px 17px -4px #666666; | ||
+ | } | ||
+ | div#wrapper { | ||
+ | position: relative; | ||
+ | width: 885px; | ||
+ | font-size: 12pt; | ||
+ | padding: 50px 40px; | ||
+ | margin: 0 auto; | ||
+ | background: #ffffff; | ||
+ | } | ||
+ | div#header { | ||
+ | height: 185px; | ||
+ | } | ||
+ | div#header div#logo { | ||
+ | position: relative; | ||
+ | width: 400px; | ||
+ | height: 125px; | ||
+ | margin: 0 auto; | ||
+ | } | ||
+ | div#header div#logo { | ||
+ | margin-bottom: 20px; | ||
+ | } | ||
+ | div#navigation { | ||
+ | width: 100%; | ||
+ | height: 40px; | ||
+ | background: #000000; | ||
+ | } | ||
+ | ul#navigation-list { | ||
+ | height: 40px; | ||
+ | line-height: 40px; | ||
+ | overflow: auto; | ||
+ | } | ||
+ | ul#navigation-list > li { | ||
+ | float: left; | ||
+ | } | ||
+ | ul#navigation-list > li > ul { | ||
+ | position: absolute; | ||
+ | display: none; | ||
+ | background: #000000; | ||
+ | z-index: 100000; | ||
+ | } | ||
+ | ul#navigation-list > li > ul.submenu { | ||
+ | margin: 0; | ||
+ | } | ||
+ | ul#navigation-list > li > ul.submenu li { | ||
+ | padding: 5px 0px; | ||
+ | } | ||
+ | ul#navigation-list a.navlink { | ||
+ | color: #ffffff; | ||
+ | font-weight: bold; | ||
+ | display: block; | ||
+ | padding: 0px 14px; | ||
+ | text-decoration: none; | ||
+ | } | ||
+ | ul#navigation-list a.navlink.active, | ||
+ | ul#navigation-list a.navlink:hover { | ||
+ | color: #ff0000; | ||
+ | } | ||
+ | div#home-main-image { | ||
+ | text-align: center; | ||
+ | } | ||
+ | div#home-main-image img { | ||
+ | width: 885px; | ||
+ | height: 300px; | ||
+ | margin-bottom: 20px; | ||
+ | border-radius: 20px; | ||
+ | } | ||
+ | div.text-box { | ||
+ | background: #444444; | ||
+ | color: #ffffff; | ||
+ | padding: 15px 20px; | ||
+ | border-radius: 10px; | ||
+ | } | ||
+ | div#footer-box { | ||
+ | border-radius: 0 0 5px 5px; | ||
+ | } | ||
+ | </style> | ||
+ | <script type="text/javascript" src="http://code.jquery.com/jquery-1.8.2.min.js"></script> | ||
+ | <script type="text/javascript"> | ||
+ | $('document').ready(function() { | ||
+ | $('li.submenu-holder').hover(function() { | ||
+ | $(this).children('ul.submenu').stop(true).fadeIn('slow'); | ||
+ | }, function() { | ||
+ | $(this).children('ul.submenu').stop(true).fadeOut('slow'); | ||
+ | }); | ||
+ | }); | ||
+ | </script> | ||
- | + | </head> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
+ | <body> | ||
- | < | + | <div id="wrapper"> |
- | + | <div id="header"> | |
- | + | <div id="logo"> | |
- | + | <a href="https://2012.igem.org/Team:Westminster"> | |
- | + | <img src="https://static.igem.org/mediawiki/2012/1/1e/Westminster-logo.png" alt="iSTEM" title="Back to home!" /> | |
- | + | </a> | |
- | + | </div><!-- #logo --> | |
- | + | <div id="navigation"> | |
- | + | <ul id="navigation-list"> | |
- | + | <li><a href="https://2012.igem.org/Team:Westminster" class="navlink active">Home</a></li> | |
- | + | <li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</a></li> | |
- | + | <li><a href="https://igem.org/Team.cgi?year=2012&team_name=Westminster"class="navlink">Team Profile</a></li> | |
+ | <li class="submenu-holder"> | ||
+ | <a href="https://2012.igem.org/Team:Westminster/Project"class="navlink">Project</a> | ||
+ | <ul class="submenu"> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Overview"class="navlink">Overview</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Problem"class="navlink">The Problem</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Experiments"class="navlink">Experiments</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Protocols"class="navlink">Protocols</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Results"class="navlink">Results</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li> | ||
+ | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Journal"class="navlink">Journal</a></li> | ||
+ | </ul> | ||
+ | </li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Parts"class="navlink">Parts</a></li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Modeling"class="navlink">Modeling</a></li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Notebook"class="navlink">Notebook</a></li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Safety"class="navlink">Safety</a></li> | ||
+ | <li><a href="https://2012.igem.org/Team:Westminster/Attributions"class="navlink">Attributions</a></li> | ||
+ | </ul><!-- #navigation-list --> | ||
+ | </div><!-- #navigation --> | ||
+ | </div><!-- #header --> | ||
+ | <div id="the-content"> | ||
+ | <div id="home-main-image"> | ||
+ | <img src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" alt="Welcome" title="Welcome to our home!" /> | ||
+ | </div><!-- #home-main-image --> | ||
+ | <div id="home-main-text" class="text-box"> | ||
+ | <h1>Lorem Ipsum</h1> | ||
+ | <p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p> | ||
- | |||
- | |||
- | |||
- | |||
+ | <p>The Westminster iGEM 2012 team aims to combat cancer recurrence by using one key feature of CSCs – increased Aldehyde Dehydrogenase (ALDH) activity. We have used the promoters of 4 different ALDH isoforms present in aggressive forms of cancer to design 3 constucts that will allow us to identify, isolate and eliminate CSC, offering a novel tool for the study of this cells and a potential new anti-cancer therapy for the future.</p> | ||
+ | </div><!-- #home-main-text --> | ||
+ | </div><!-- #the-content --> | ||
+ | </div><!-- #wrapper --> | ||
- | + | </body> | |
- | + | </html> | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | </ | + | |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 19:31, 25 September 2012
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
The Westminster iGEM 2012 team aims to combat cancer recurrence by using one key feature of CSCs – increased Aldehyde Dehydrogenase (ALDH) activity. We have used the promoters of 4 different ALDH isoforms present in aggressive forms of cancer to design 3 constucts that will allow us to identify, isolate and eliminate CSC, offering a novel tool for the study of this cells and a potential new anti-cancer therapy for the future.